Differential prognosis of single and multiple TP53 abnormalities in high-count MBL and untreated CLL

Authors: Griffin, Rosalie, Wiedmeier-Nutor, Julia E., Parikh, Sameer A., McCabe, Chantal E., O'Brien, Daniel R., Boddicker, Nicholas J., Kleinstern, Geffen, Rabe, Kari G., Bruins, Laura, Brown, Sochilt, Bonolo de Campos, Cecilia, Ding, Wei, Leis, Jose F., Hampel, Paul J., Call, Timothy G., Van Dyke, Daniel L., Kay, Neil E., Cerhan, James R., Yan, Huihuang, Slager, Susan L., Braggio, Esteban

Source: In Blood Advances 11 July 2023 7(13):3169-3179

CLL update 2022: A continuing evolution in care

Authors: Kay, Neil E., Hampel, Paul J., Van Dyke, Daniel L., Parikh, Sameer A.

Source: In Blood Reviews July 2022 54

Utilizing next-generation sequencing to characterize a case of acute myeloid leukemia with t(4;12)(q12;p13) in the absence of ETV6/CHIC2 and ETV6/PDGFRA gene fusions

Authors: Koleilat, Alaa, McGarrah, Patrick W., Olteanu, Horatiu, Van Dyke, Daniel L., Smadbeck, James B., Johnson, Sarah H., Vasmatzis, George, Hoppman, Nicole L., Xu, Xinjie, Ketterling, Rhett P., Greipp, Patricia T., Baughn, Linda B., Patnaik, Mrinal S., Peterson, Jess F.

Source: Cancer genetics. 260:1-5

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100155615735.0x000001&indx=1&recIds=ETOCvdc_100155615735.0x000001

Typical, atypical and cryptic t(15;17)(q24;q21) (PML::RARA) observed in acute promyelocytic leukemia: A retrospective review of 831 patients with concurrent chromosome and PML::RARA dual‐color dual‐fusion FISH studies

Authors: Gagnon, Marie‐France, Berg, Holly E., Meyer, Reid G., Sukov, William R., Van Dyke, Daniel L., Jenkins, Robert B., Greipp, Patricia T., Thorland, Erik C., Hoppman, Nicole L., Xu, Xinjie, Baughn, Linda B., Reichard, Kaaren K., Ketterling, Rhett P., Peterson, Jess F.

Source: Genes, chromosomes & cancer. 61(10):629-634

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100157790972.0x000001&indx=1&recIds=ETOCvdc_100157790972.0x000001

Differential transcriptomic profiling in ibrutinib‐naïve versus ibrutinib‐resistant Richter syndrome

Authors: Wang, Hanyin, Tian, Shulan, Zhao, Qing, Blumenschein, Wendy, Yearley, Jennifer H., Secreto, Charla R., Sinha, Sutapa, Call, Timothy G., Wang, Yucai, Parikh, Sameer A., Kenderian, Saad S., He, Rong, Leis, Jose F., Shi, Min, Van Dyke, Daniel L., Kay, Neil E., Slager, Susan L., Braggio, Esteban, Yan, Huihuang, Ding, Wei

Source: Hematological oncology. 40(2):302-306

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100146719761.0x000001&indx=1&recIds=ETOCvdc_100146719761.0x000001

MCIR1: A patient‐derived mantle cell lymphoma line for discovering new treatments for ibrutinib resistance

Authors: Wu, Xiaosheng, Nowakowski, Kevin E., Abeykoon, Jithma P., Manske, Michelle, Stenson, Mary J., Timm, Michael M., Hanson, Curtis A., Van Dyke, Daniel L., Dasari, Surendra, Witzig, Thomas E.

Source: European journal of haematology. 107(4):458-465

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100129112267.0x000001&indx=1&recIds=ETOCvdc_100129112267.0x000001

The prognostic significance of del6q23 in chronic lymphocytic leukemia

Authors: Audil, Hadiyah Y., Hampel, Paul J., Van Dyke, Daniel L., Achenbach, Sara J., Rabe, Kari G., Smoley, Stephanie A., Call, Timothy G., Ding, Wei, Shi, Min, Hanson, Curtis A., Wang, Yucai, Muchtar, Eli, Koehler, Amber B., Schwager, Susan M., Leis, Jose F., Braggio, Esteban, Slager, Susan L., Kay, Neil E., Kenderian, Saad S., Parikh, Sameer A.

Source: American journal of hematology. 96(6):E203-E206

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100120465539.0x000001&indx=1&recIds=ETOCvdc_100120465539.0x000001

Conventional Cytogenetic Analysis of Hematologic Neoplasms: A 20-Year Review of Proficiency Test Results From the College of American Pathologists/American College of Medical Genetics and

Authors: Larson, Daniel P., Akkari, Yassmine M., Van Dyke, Daniel L., Raca, Gordana, Gardner, Juli-Anne, Rehder, Catherine W., Kaiser-Rogers, Kathleen A., Eagle, Penny, Yuhas, Jason A., Gu, Jun

Source: Archives of pathology & laboratory medicine. 145(2):176-190

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN631329925&indx=1&recIds=ETOCRN631329925

Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia

Authors: Hampel, Paul J., Call, Timothy G., Rabe, Kari G., Ding, Wei, Muchtar, Eli, Kenderian, Saad S., Wang, Yucai, Leis, Jose F., Witzig, Thomas E., Koehler, Amber B., Fonder, Amie L., Schwager, Susan M., Van Dyke, Daniel L., Braggio, Esteban, Slager, Susan L., Kay, Neil E., Parikh, Sameer A.

Source: Oncologist. 25(11):974-980

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100109216792.0x000001&indx=1&recIds=ETOCvdc_100109216792.0x000001

Addition of venetoclax at time of progression in ibrutinib‐treated patients with chronic lymphocytic leukemia: Combination therapy to prevent ibrutinib flare

Authors: Hampel, Paul J., Call, Timothy G., Ding, Wei, Muchtar, Eli, Kenderian, Saad S., Wang, Yucai, Leis, Jose F., Witzig, Thomas E., Koehler, Amber B., Fonder, Amie L., Schwager, Susan M., Rabe, Kari G., Van Dyke, Daniel L., Braggio, Esteban, Slager, Susan L., Kay, Neil E., Parikh, Sameer A.

Source: American journal of hematology. 95(3):E57-E60

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100102868991.0x000001&indx=1&recIds=ETOCvdc_100102868991.0x000001

Assessing copy number aberrations and copy-neutral loss-of-heterozygosity across the genome as best practice: An evidence-based review from the Cancer Genomics Consortium (CGC) working group for chronic lymphocytic leukemia

Authors: Chun, Kathy, Wenger, Gail D., Chaubey, Alka, Dash, D.P., Kanagal-Shamanna, Rashmi, Kantarci, Sibel, Kolhe, Ravindra, Van Dyke, Daniel L., Wang, Lu, Wolff, Daynna J., Miron, Patricia M.

Source: In Cancer Genetics December 2018 228-229:236-250

Characterization of a t(1;2)(p36;p21) involving the PRDM16 gene region by mate-pair sequencing (MPseq) in a patient with newly diagnosed acute myeloid leukemia with myelodysplasia-related changes

Authors: Muppa, Prasuna, Van Dyke, Daniel L., Bianco, Michelle K., Pitel, Beth A., Smoley, Stephanie A., Vasmatzis, George, Smadbeck, James B., Sukov, William R., Greipp, Patricia T., Ketterling, Rhett P., Baughn, Linda B., Peterson, Jess F.

Source: Journal of hematopathology. 12(2):85-90

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100124738973.0x000001&indx=1&recIds=ETOCvdc_100124738973.0x000001

Multiple isodicentric Y chromosomes in myeloid malignancies: a unique cytogenetic entity and potential therapeutic target

Authors: Mangaonkar, Abhishek A., Patnaik, Mrinal M., Oliver, Gavin R., Rao, Kathleen W., Kaiser-Rogers, Kathleen, Davila, Jaime I., Fadra, Numrah, Wehrs, Rebecca N., Elliott, Michelle A., Greipp, Patricia T., Halling, Kevin C., Van Dyke, Daniel L.

Source: Leukemia & lymphoma. 60(3):821-824

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100078940298.0x000001&indx=1&recIds=ETOCvdc_100078940298.0x000001

Analysis of Common Abnormalities Seen in Chronic Lymphocytic Leukemia Using Fluorescence In Situ Hybridization

Authors: Meyer, Reid G., Van Dyke, Daniel L.

Source: Methods in molecular biology. 1881:35-50

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN618002504&indx=1&recIds=ETOCRN618002504

Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL

Authors: Ding, Wei, LaPlant, Betsy R., Call, Timothy G., Parikh, Sameer A., Leis, Jose F., He, Rong, Shanafelt, Tait D., Sinha, Sutapa, Le-Rademacher, Jennifer, Feldman, Andrew L., Habermann, Thomas M., Witzig, Thomas E., Wiseman, Gregory A., Lin, Yi, Asmus, Erik, Nowakowski, Grzegorz S., Conte, Michael J., Bowen, Deborah A., Aitken, Casey N., Van Dyke, Daniel L., Greipp, Patricia T., Liu, Xin, Wu, Xiaosheng, Zhang, Henan, Secreto, Charla R., Tian, Shulan, Braggio, Esteban, Wellik, Linda E., Micallef, Ivana, Viswanatha, David S., Yan, Huihuang, Chanan-Khan, Asher A., Kay, Neil E., Dong, Haidong, Ansell, Stephen M.

Source: In Blood 29 June 2017 129(26):3419-3427

Utility of Targeted Sequencing Compared to FISH for Detection of Chronic Lymphocytic Leukemia Copy Number Alterations.

Authors: Wiedmeier-Nutor, J. Erin, McCabe, Chantal E., O'Brien, Daniel R., Jessen, Erik, Bonolo de Campos, Cecilia, Boddicker, Nicholas J., Griffin, Rosalie, Allmer, Cristine, Rabe, Kari G., Cerhan, James R., Parikh, Sameer A., Kay, Neil E., Yan, Huihuang, Van Dyke, Daniel L., Slager, Susan L., Braggio, Esteban

Source: Cancers; Jul2024, Vol. 16 Issue 13, p2450, 11p

Subject Terms: CHRONIC lymphocytic leukemia diagnosis, CHRONIC lymphocytic leukemia, RESEARCH funding, CHROMOSOME abnormalities, DESCRIPTIVE statistics, LONGITUDINAL method, KARYOTYPES, FLUORESCENCE in situ hybridization, GENETIC mutation, GENETIC techniques, SEQUENCE analysis, GENOMES, SENSITIVITY & specificity (Statistics)

Interphase Chromosome Profiling: A Method for Conventional Banded Chromosome Analysis Using Interphase Nuclei

Authors: Babu, Ramesh, Van Dyke, Daniel L., Dev, Vaithilingam G., Koduru, Prasad, Rao, Nagesh, Mitter, Navnit S., Liu, Mingya, Fuentes, Ernesto, Fuentes, Sarah, Papa, Stephen

Source: Archives of pathology & laboratory medicine. 142(2):213-228

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN631237470&indx=1&recIds=ETOCRN631237470

Isolated trisomy 2 in bone marrows of patients with suspected hematopoietic malignancies

Authors: Aypar, Umut, Reichard, Kaaren K., Waltman, Lindsey A., Van Dyke, Daniel L.

Source: In Cancer Genetics April 2014 207(4):124-127

Subjectivity in chromosome band–level estimation: a multicenter study

Authors: Geiersbach, Katherine B., Gardiner, Anna E., Wilson, Andrew, Shetty, Shashirekha, Bruyère, Hélène, Zabawski, James, Saxe, Debra F., Gaulin, Rebecca, Williamson, Cynthia, Van Dyke, Daniel L.

Source: In Genetics in Medicine February 2014 16(2):170-175

Treatment Patterns and Outcomes of Patients with Chronic Lymphocytic Leukemia with TP53 Mutations

Authors: Hwang, Steven R, Wang, Yucai, Rabe, Kari G ^*, He, Rong, Kenderian, Saad S., Muchtar, Eli, Hampel, Paul J., Kay, Neil E., Call, Timothy G., Koehler, Amber ^*, Behnken, Amy L ^*, Leis, Jose F., Braggio, Esteban, Shi, Min, Viswanatha, David S., Van Dyke, Daniel L., Slager, Susan L., Parikh, Sameer A., Ding, Wei

Source: In Blood 15 November 2022 140 Supplement 1:12390-12392